The effect of Mesenchymal Stem Cells of Amniotic Membrane on the Proliferation and Differentiation of Umbilical Cord Blood CD34+ cells
Archives of Advances in Biosciences,
Vol. 11 No. 1 (2020),
8 January 2020
,
Page 16-25
https://doi.org/10.22037/aab.v11i1.27546
Abstract
Introduction: Ex vivo proliferation of hematopoietic stem cells (HSCs) of umbilical cord is widely used by combination of cytokine and stromal mesenchymal stem cells (MSCs) as feeder layer due to increase the cell doses, adequately. However, numerous studies have shown that ex vivo proliferation of these cells impairs their functions, including reduced self-renewal ability, apoptosis induction, and disordered cell cycle. MSCs have different sources such as amniotic membrane with a stable karyotype and high quality because of isolation from embryonic tissues, so that they are considered as a useful source for MSCs.
Materials and Methods: In this study, isolated mesenchymal cells from the amniotic membrane were used as feeders for the HSCs proliferation. Four different cultures with various conditions were used; first one containing cytokines (stem cell factor, thrombopoietin, and FMS-related tyrosine kinase 3 ligand), second one with MSCs co-cultured with the aforementioned cytokines, third medium co-cultured with MSCs without cytokines, and finally the control medium was without co-culture condition and cytokines. Expression of mRNAs of HOXB4, GATA2, BCL2, and Survivin genes was also investigated.
Results: The findings showed that the expression of mRNAs of these genes decreased in culture with cytokine, solely; however the expression of these genes was significantly higher in co-cultured system with cytokine rather than just with cytokine.
Conclusion: : In general, the findings of this study indicate that the derived MSCs from amniotic membrane is a good source for the proliferation of umbilical cord blood CD34+ cells”. Because these cells increase the UCB-CD34+ quantity and their preservation properties.
- Amniotic Membrane
- Co-culture
- Hematopoietic Stem Cells
- Mesenchymal Stem Cells
- UCB-CD34
How to Cite
References
Baksh D., Davis J.E., Zandstra P.W. Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion. Journal of international Society for Hematology 2003; 31: 723-732.
Beachy P.A., Karhadkar S.S., Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature; 2004; 432(7015):324-31.
Adewumi O., Aflatoonian B., Ahrlund-Richter L, Amit M., Andrews P.W., Beighton G. Characterization of human embryonic stem cell lines by the interna-tional stem cell initiative. National Biotechnology; 2007; 25: 803-816.
Sanchez-Ramos J. Stem cells from umbilical cord blood. Semin Reprod Med. 2006; 24(5):358-69.
Tancharoen W., Auqsuchawan S., Pothacharoen P., Markmee R., Narakornsak S., kieodee J., Boonma N., Tasuya W.. Differentiation of mesenchymal stem cells from human amniotic fluid to vascular endothelial cells. Acta Histochemistry; 2017; 119(2):113-121.
Baldridge M.T., King K.Y., Boles N.C., Weksberg D.C., Goodell M.A. Quiescent haematopoietic stem cellsare activated by IFN-gamma in response to chronic infection. Nature; 2010; 465(7299):793-797
Lu L., Xiao M., Shen R.N., Grisby S., Broxmeyer H.E. Enrichment,characterization and responsiveness of single primitive CD34+ human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood; 1993; 81:41.
Medvinsky A., Dzierzak E. Development of the hematopoietic stem cell: can we describe it? Blood; 1999; 94(10):3613-4.
Kumar R. allogenichematopoitic stem cell transplanation in hematologic disorders. Recent advances in hematology; 2011; 141-158.
Gluckman E., Rocha V., Chevret S. Results of unrelated umbilical cord blood hematopoietic stem cell transplantation. Review in Clinical and Experimental Hematology; 2001; 5:87–99. [PubMed: 11486656]
Barker J.N., Weisdorf D.J., Defor T.E., Blazar B.R., McGlave P.B., Miller J.S. et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood; 2005; 105:1343–1347. [PubMed: 15466923]
Andrade-zaldivar H., Santos L., De Leon Rodriguez A. Expansion of human hematopoietic stem cells for transplantation: trends and perspectives. Cytotechnology; 2008; 56:151-160.
Zhang Y.J., Yang Y.X., Hu M.Y., Ni Q.K., Li H.G., Miao Z.C. Importance of CD 44 on umbilical cord mesenchymal stem cells for expansion of hematopoietic cells. Cellular and molecular biology; 2015; 61(2):18-25.
Koller MR, Oxender M, Brott DA, Palsson BO. FIt-3 ligand is more potent than c¬kit ligand for the synergistic stimulation of ex vivo hematopoietic cell expansion. J Hematother 1996; 5(5):449-59.
Tian L, Yaojiong W. Paracrine Molecules of Mesenchymal Stem Cells for Hematopoietic Stem Cell Niche. Bone Marrow Res 2011; 353878.
Wang C., Li Y., Zou Y., Liu H., Liang Z., Yin Y., Niu G., Yan Z., Zhang B. Efficient Differentiation of Bone Marrow Mesenchymal Stem Cells into Endothelial Cells in Vitro. European Journal of Vascular and Endovascular Surgery; 2018; 55(2):257-265.
Sandhaanam SD, Pathalam G, Dorairaj S, Savariar V. Mesenchymal stem cells (MSC): Identification, Proliferation and Differentiation. PeerJ PrePrints 1: 2013; e148v1.
Charbord P., Casteilla L. Human mesenchymal stem cell biology. Medical Science; 2011; 27(3):261-7.
Blank U., Karlsson G., Karlsson S. Signaling pathways governing stem cell fate. Blood; 2008; 111:492–503.
Shpall E.J., Quinones R., Giller R., Zeng C., Baron A.E., Jones R.B., Bearman S.I., Nieto Y., Freed B., Madinger N., Hogan C.J., Slat-Vasquez V., Russell P., Blunk B., Schissel D., Hild E., Malcolm J., Ward W., McNiece I.K. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant; 2002; 8:368–376. [PubMed: 12171483].
Domen J., Cheshier S.H., Weissman I.L. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. Journal of Experimental Medicine; 2000; 191(2):253-64.
Kutschka I., Kofidis T., Chen I.Y., von Degenfeld G., Zwierzchoniewska M., Hoyt G., Arai T., Lebl D.R., Hendry S.L., Sheikh A.Y., Cooke D.T., Connolly A., Blau H.M., Gambhir S.S., Robbins R.C. Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts. Circulation; 2006; 114 (1, Suppl) I 174–I180.
Fukuda S., Singh P., Moh A., Abe M., Conway E.M., Boswell H.S., et al. Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3. Blood; 2009; 114(2):394-403.
Fukuda S., Pelus L.M. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34+ cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood; 2001; 98(7):2091-1 00.
Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS, et al. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 1994; 91(25): 12223.
Takashi Moriguchi, Mikiko Suzuki, James Douglas Engel, and Masayuki Yamamoto. GATA1 and GATA2 Function in Hematopoietic Differentiation. Book: Hematopoietic Stem Cell Biology. Motonari Kondo.pp 2010; 117-136.
Koga S., Yamaguchi N., Abe T., Minegishi M., Tsuchiya S., Yamamoto M, et al. Cell¬cycle-dependent oscillation of GATA2 expression in hematopoietic cells. Blood; 2007; 1 09(1 0):4200.
Ling K.W., Ottersbach K., Van Hamburg J.P., Oziemlak A., Tsai F.Y., Orkin S.H., et al. GAT A-2 plays two functionally distinct rolesduring the ontogeny of hematopoietic stem cells. Journal of medicinal chemistry; 2004; 200(7):871-82.
Gallacher L., Murdoch B., Wu D.M., Karanu F.N., Keeney M., Bhatia M. Isolation and characterization of human CD34- Lin- and CD34? Lin- hematopoietic stem cells using cell surface markers AC133 and CD7. Blood; 2000; 95:2813–2821.
Portmann-Lanz CB1, Schoeberlein A, Huber A, Sager R, Malek A, Holzgreve W, Surbek DV. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol. 2006 Mar; 194(3):664-73.
Dahlberg A., Delaney C., Bernstein I. Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood; 2011; 117:6083 –90.
Mayani H., Dragowska W., Lansdorp P. Lineage commitment in human hemopoiesis involves asymmetric cell division of multipotent progenitors and does not appear to be influenced by cytokines. Journal of Cell Physiology; 1993; 157(3): 579-86.
Robinson S.N., Ng J., Niu T., Yang H., McMannis J.D., Karandish S., Kaur I., Fu P., Del Angel M., Messinger R., Flagge F., de Lima M., Decker W., Xing D., Champlin R., and Shpall E.J.Superior ex vivo cord blood expansion following co-culture withbone marrow-derived mesenchymal stem cell. Bone Marrow Transplant; 2006; 37(4): 359–366.
kadekar D., Kale V., Limaye L. Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34+ cells. Stem Cell Research & Therapy; 2015; 6:201
Flores–Guzman P., Fernandez–Sanchezv V., Mayani H. Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine. Stem Cells Translational Medicine; 2013; 2:830 – 8.
Sherley lL, Taghizadeh RR. Investigation of a suppression of asymmetric cell kinetics (SACK) approach for ex vivo expansion of human hematopoietic stem cells: Massachusetts Institute of Technology; 2006.
McGuckin C, Forraz N, Pettengell R, Thompson A. Thrombopoietin, flt3-1igand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133+ cells. Cell Prolif 2004; 37(4):295-306.
Tang YH, Fei XM, Shen WY, Miao KR, Cui YG, Wang CY. Expression of HOXB4 in cQJ: Q. blood progenitor cells expanded in vitro. Zhong guo Shi Yan Xu Ye XueZaZhi 2006; 14(1):89-93.
Holmes T., Yan F., Ko K.H., Norden R., Song E., O'Brien T.A., Dolnikov A. Ex vivo of cord blood progenitors impairs their short-term and-long-term repopulati g activity associated with transcriptional dysregulation of signalling networks. Cell proliferation; 2012; 45(3):266-78.
Bowman T.V., Zon L.I. Lessons from the Niche for Generation and Expansion of Hematopoietic Stem Cells. Drug Discovery Today: Therapeutic Strategies; 2009; 6(4):135-140.
Celebi B., Mantovani D., Pineault N. Irradiated mesenchymal stem cells improve the ex vivo expansion of hematopoietic rogenitors by partly mimicking the bone marrow endosteal environment. Journal of Immunology Methods; 2011; 370:93– 103.
Walenda T., Bork S., Horn P., Wein F., Saffrich R., Diehlmann A,. Eckstein V., Ho A.D., Wagner W. Co-culture with mesenchymal stromal cells increases proliferation and maintenance of haematopoietic progenitor cells. Journal of Cell Molecular; 2010; 14:337 – 50.
- Abstract Viewed: 108 times
- PDF Downloaded: 83 times